Lucia, F., Bourbonne, V., PLEYERS, C., Dupré, P.-F., Miranda, O., Visvikis, D., Pradier, O., Abgral, R., Mervoyer, A., Classe, J.-M., Rousseau, C., Vos, W., HERMESSE, J., Gennigens, C., De Cuypere, M., Kridelka, F., Schick, U., Hatt, M., Hustinx, R., & Lovinfosse, P. (2023). Multicentric development and evaluation of 18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06180-w |
Dheur, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kridelka, F., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kakkos, A. (October 2022). 2022-RA-193-ESGO Cost-effectiveness of molecular profiling for endometrial neoplasia: a single institution experience. Poster session presented at 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.203 |
DHEUR, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kakkos, A., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kridelka, F. (29 September 2022). Defining prognostic risk groups amongst patients with endometrial cancer:respective role of 2009 figo stage and molecular profile. Poster session presented at IGCS 2022, New York, United States. |
Colassin, A., Denis, C., HERMESSE, J., WALTREGNY, D., & SAUTOIS, B. (May 2021). Prise en charge d'un cancer de la prostate métastatique au diagnostic. Revue Médicale de Liège, 76 (5-6), 496-501. |
Da Silva Ferreira, M., LOVINFOSSE, P., HERMESSE, J., DE CUYPERE, M., Rousseau, C., Lucia, F., Schick, U., Reinhold, C., Robin, P., Hatt, M., Visvikis, D., Bernard, C., Leijenaar, R. T. H., Kridelka, F., Lambin, P., Meyer, P., & Hustinx, R. (2021). [(18)F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05303-5 |
GENNIGENS, C., DE CUYPERE, M., HERMESSE, J., KRIDELKA, F., & JERUSALEM, G. (2021). Optimal treatment in locally advanced cervical cancer. Expert Review of Anticancer Therapy, 657-671. doi:10.1080/14737140.2021.1879646 |
LAPAILLE, L., DE CUYPERE, M., GOFFIN, F., KAKKOS, A., GONNE, E., HERMESSE, J., LOVINFOSSE, P., DELBECQUE, K., THILLE, A., Kridelka, F., & GENNIGENS, C. (2021). Cancer du col utérin localement avancé : approche multidisciplinaire. Revue Médicale de Liège, 76 (5-6), 507-514. |
HERMESSE, J., NICKERS, P., REUL, O., & COUCKE, P. (2014). LA CURIETHÉRAPIE PROSTATIQUE PAR IMPLANTS PERMANENTS D'IODE 125- résultats après 10 ans d'expérience au CHU de Liège. Revue Médicale de Liège, 69 (Supp 1), 32-36. |
HERMESSE, J., WERENNE, X., PHILIPPI, S., & COUCKE, P. (2014). INDICATIONS D’UN TRAITEMENT DE RADIOTHERAPIE LOCALE APRES PROSTATECTOMIE RADICALE. Revue Médicale de Liège, 69 (Supp 1), 29-31. |
WERENNE, X., HERMESSE, J., PIRET, P., COUCKE, P., & KRIDELKA, F. (2012). Radiothérapie dans le cadre d’une maladie de Paget touchant la région génitale. Revue Médicale de Liège, 67 (2), 61-63. |
Hermesse, J., Biver, S., JANSEN, N., LENAERTS, E., De Patoul, N., Vynckier, S., COUCKE, P., Scalliet, P., & Nickers, P. (2009). A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy. Strahlentherapie und Onkologie, 185 (11), 736-742. doi:10.1007/s00066-009-2009-5 |
Hermesse, J., Thissen, B., Warlimont, B., Jansen, N., Coucke, P., & Niockers, P. (2008). Analysis of Dose Volume Histogram Differences between High Dose Rate Brachytherapy and Intensity Modulated Radiotherapy for Prostate Treatment. International Journal of Radiation, Oncology, Biology, Physics, 72 (1 (supplément)), 566. doi:10.1016/j.ijrobp.2008.06.140 |
Hermesse, J., Devillers, M., Deneufbourg, J.-M., & Nickers, P. (March 2005). Can intensity-modulated radiation therapy of the Paraaortic region overcome the problems of critical organ tolerance? Strahlentherapie und Onkologie, 181 (3), 185-190. doi:10.1007/s00066-005-1324-8 |